Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -66,602 | -45,299 | -23,042 | N/A |
| Depreciation Amortization | N/A | 1,420 | 1,009 | 549 | N/A |
| Accounts payable and accrued liabilities | N/A | -1,911 | -81 | -678 | N/A |
| Other Working Capital | N/A | 6,279 | -3,582 | -3,356 | N/A |
| Other Operating Activity | 0 | 8,189 | 4,617 | 3,785 | 0 |
| Operating Cash Flow | $N/A | $-52,625 | $-43,336 | $-22,742 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1,127 | -1,112 | -920 | N/A |
| Purchase Of Investment | N/A | -63,757 | -10,102 | -10,102 | N/A |
| Sale Of Investment | N/A | 112,509 | 61,356 | 41,066 | N/A |
| Investing Cash Flow | $N/A | $47,625 | $50,142 | $30,044 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 58,149 | 336 | 168 | N/A |
| Financing Cash Flow | $N/A | $58,149 | $336 | $168 | $N/A |
| Exchange Rate Effect | N/A | 1,168 | 711 | -339 | N/A |
| Beginning Cash Position | N/A | 30,732 | 30,732 | 30,732 | N/A |
| End Cash Position | N/A | 85,049 | 38,585 | 37,863 | N/A |
| Net Cash Flow | $N/A | $54,317 | $7,853 | $7,131 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -52,625 | -43,336 | -22,742 | N/A |
| Capital Expenditure | N/A | -1,127 | -1,112 | -920 | N/A |
| Free Cash Flow | 0 | -53,752 | -44,448 | -23,662 | 0 |